A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR 0.72) versus SoC alone, with positive trend in OS (HR 0.84) in PSMA+ metastatic ...
Swiss drugmaker Novartis said on Sunday its targeted radiotherapy treatment Pluvicto reduced the risk of progression or death ...
In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...
One in eight men in the United States will be diagnosed with prostate cancer in their lifetime. The prostate is a gland in the male reproductive system that produces seminal fluid. Prostate cancer ...
Hanwha Life said on the 29th it obtained a six-month exclusive-use right from the Korea Life Insurance Association’s new product review committee for three new male-coverage riders. The riders granted ...
This is read by an automated voice. Please report any issues or inconsistencies here. Tennis legend Björn Borg talks in a new autobiography about the cocaine and alcohol abuse that came after he ...
WASHINGTON — Former President Joe Biden recently underwent surgery to remove cancerous cells from his skin, his spokesperson confirmed to NBC News on Thursday. Biden’s personal office said he is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback